Tim Sturgeon

Director, Europe

Tim has over 5 years’ of healthcare investment banking experience, having joined Results in 2016 as an Associate. He has worked with early stage and founder-led companies, private equity and corporate clients on a variety of transactions and projects including divestments, acquisitions, fundraising, investments and strategic reviews. He has advised investors, pharma, biotech and healthtech clients as well as outsourced providers of manufacturing, research, and commercial services to the life science industry.

Prior to Results Tim spent 7 years in the biopharma industry, the first 4 of which as a development scientist in a CDMO before moving into a corporate role at an early-stage biotech company. Tim holds a Masters degree in Biochemical Engineering and has passed Level II of the CFA program.

Outside of work, Tim enjoys surfing, snowboarding and bouldering.

Latest Insights

1st February 2022

Pharma Commercialisation Services Update – February 2022

We are pleased to introduce you to the first of our regular sector updates on the outsourced pharma commercialisation sector.  For some time, Results Healthcare has been producing sector updates and whitepapers on the two other major areas pharmaceutical companies choose to outsource: manufacturing and research. This report focuses on commercialisation, encompassing Healthcare Marketing, Market […]

4th July 2019

CRO sector M&A drivers and market trends

Contract Research Organisations (CROs) typically provide discovery and development services to the pharmaceutical, biotechnology and medical devices industries (frequently referred to as sponsors), but can also support foundations, research institutions and universities. CROs co-ordinate and execute activities throughout the R&D pathway, by organising and conducting clinical trials to test the new molecule in humans. As […]